The primary objective of this review is to explore and critically analyze recent advancements in pharmaceutical packaging technologies and their impact on drug safety, stability, and supply chain management. Specifically, the review aims to:

· Highlight emerging technologies such as smart packaging, RFID, anti-counterfeit solutions, and sustainable materials.

· Discuss the role of innovative packaging in enhancing patient compliance and drug efficacy.

· Examine modern evaluation strategies used to assess the performance, quality, and regulatory compliance of advanced packaging systems.

· Identify current challenges and future trends shaping the pharmaceutical packaging industry.

· Through this review, we aim to provide a comprehensive understanding of how packaging innovations contribute to the overall effectiveness and security of pharmaceutical products.

INTRODUCTION:

Pharmaceutical packaging refers to the processes and materials used to enclose and protect pharmaceutical products from production through distribution to end use. It plays a critical role in ensuring the safety, efficacy, and quality of medicines, while also providing vital information to healthcare professionals and patients.

Classification of Pharmaceutical Packaging:

1. Primary Packaging:

Definition: The packaging that comes directly in contact with the pharmaceutical product.

Examples: Blister packs, bottles, ampoules, vials, prefilled syringes.

Purpose: Protects the drug from contamination, environmental factors, and ensures product integrity.

2. Secondary Packaging:

Definition: The external packaging that holds and protects the primary package.

Examples: Cartons, boxes, shrink wraps.

Purpose: Provides additional protection, supports branding, and facilitates handling, storage, and transportation.

3. Tertiary Packaging:

Definition: Packaging used for bulk handling, storage, and transportation.

Examples: Pallets, large shipping cartons, crates.

Purpose: Ensures safe and efficient distribution of large quantities of pharmaceuticals.

4. Quaternary Packaging:(sometimes mentioned in logistics-focused contexts)

Definition: Systems used for tracking, security, and further bulk handling in complex supply chains.

Examples: RFID-tagged pallets, temperature-controlled containers for international shipping.

Function of Packaging:

1. Protective function: Effective packaging safeguards the contents from static and dynamic forces during transportation and storage. By minimizing vibrations that can cause emulsion cracking, good packaging ensures product stability. It also shields the contents from biological contaminants, moisture, temperature fluctuations, environmental gases, and humidity. Furthermore, primary packaging solutions like amber-colored bottles can protect light-sensitive materials from degradation, ensuring their potency and efficacy are preserved.

2. Identification function: A packaging provide information regarding product such as date of manufacturing, expiry date, use, batch no., warnings if any,etc. It also provides an ease of identify the product for e.g colored flutted bottles are used for packaging external preparation.

3. Storage and transport function: Packaging is crucial for safe storage and transportation of products. A well-designed package shape facilitates easy handling and efficient storage, allowing packages to be stacked safely one on top of the other. Additionally, package dimensions should be optimized to fit standard pallets, ensuring maximum storage capacity and minimizing logistical challenges.

4. Other functions: Other functions of package includes protection from theft, compression, impact etc., patient compliance, effective tool for marketing^1,2.

Recent Advances In Pharmaceutical Packaging Technologies:

1. Smart intelligence packaging:

· RFID And QR code packaging

Figure 1. RFID Tags reader ³

RFID and QR code tracking are cutting-edge technologies that enhance pharmaceutical supply chain visibility, security, and efficiency. RFID tags, attached to packages or pallets, store unique identifiers and product information, enabling real-time inventory management, authentication, and recall management. QR codes, affixed to product packages or labels, provide access to product information and authentication when scanned. Both technologies help prevent counterfeiting, ensure regulatory compliance, and improve patient safety by tracking product movement and storage conditions. By leveraging RFID and QR code tracking, pharmaceutical companies can optimize inventory management, facilitate recalls, and empower patients with easy access to product information, ultimately strengthening supply chain integrity and product safety⁴.

· Temperature and humidity sensors:

Temperature and humidity indicators are compact sensors that monitor and record temperature and humidity levels within packages. These sensors can continuously or periodically measure conditions, automatically logging data to ensure product stability and safety during storage and transportation⁵. Temperature and humidity sensors are vital in pharmaceutical packaging, enabling real-time monitoring and control of environmental conditions that impact product stability and efficacy. These sensors can be disposable or reusable, depending on the specific needs of the drug and company. By tracking temperature and humidity levels, they help prevent product degradation, spoilage, or loss of potency, ensuring safety and efficacy. This technology enhances supply chain visibility, reduces product losses, and improves patient safety, while also providing valuable data for quality control, regulatory compliance, and supply chain optimization.

Tamper-evident and anti-counterfeiting features:

Tamper-evident and anti-counterfeiting features are essential in pharmaceutical packaging to safeguard product integrity, patient safety, and regulatory compliance. Counterfeit products can pose significant risks, including incorrect ingredients, lack of active ingredients, incorrect dosages, or fake packaging, which can compromise patient health and safety⁶. Tamper-evident features provide visible signs of unauthorized access or tampering, alerting consumers to potential product compromise. Examples include tamper-evident caps, seals, or labels that break or change appearance when tampered with, such as induction seals or breakable caps. These features deter tampering and protect patients from potential harm by clearly indicating if a product has been compromised.

Anti-counterfeiting measures are crucial to prevent and detect fake pharmaceuticals, which can be ineffective, toxic, or even fatal. To combat counterfeiting, pharmaceutical companies use technologies like holograms, watermarks, and serialization. Holograms are 3D images embedded in packaging, making replication difficult. Watermarks are translucent patterns or images integrated into labels or packaging, adding an authentication layer. Serialization assigns unique identifiers to each product unit, enabling real-time tracking and verification throughout the supply chain, ensuring product authenticity and safety⁷.

The integration of tamper-evident and anti-counterfeiting features in pharmaceutical packaging offers numerous benefits, including enhanced patient safety, regulatory compliance, and brand protection. These features build trust with patients and regulatory bodies, reduce financial losses due to counterfeits, and prevent the distribution of compromised products, ultimately protecting public health. Regulatory bodies like the FDA have implemented guidelines, such as requiring tamper-evident packaging for certain OTC medications. By incorporating these features and advanced technologies like RFID tags and QR codes, pharmaceutical companies can ensure product integrity, patient safety, and regulatory compliance, while protecting their brand reputation and reducing counterfeit-related losses⁸.

2. Sustainable and Eco-Friendly Packaging:

Figure 2 : Sustainable and biodegradable packaging materials used in pharmaceuticals³¹

· Biodegradable polymers and plant-based materials:

Biodegradable and plant-based materials are transforming pharmaceutical packaging with sustainable, eco-friendly alternatives to traditional materials. Derived from renewable resources like corn starch, sugarcane, or potato starch, these materials naturally break down, reducing waste and pollution, and promoting a more environmentally responsible packaging solution^9,10. Biodegradable packaging materials like bioplastics and paper-based packaging can be composted, minimizing the environmental impact of pharmaceutical packaging. Plant-based materials can also be used for caps, closures, labels, and inserts, creating a fully sustainable packaging system. By adopting these eco-friendly materials, pharmaceutical companies can reduce their environmental footprint, promote sustainability, and support a circular economy¹¹.This shift towards sustainable packaging not only reduces the industry's ecological footprint but also meets growing consumer demand for eco-friendly products, boosting brand reputation and customer loyalty. By using biodegradable and plant-based materials, pharmaceutical companies can comply with stringent environmental regulations, cut waste disposal costs, and benefit both the environment and their business operations.

· Recyclable and compostable packaging:

Recyclable and compostable packaging is revolutionizing the pharmaceutical industry with a more sustainable approach. Recyclable materials like paper, cardboard, glass, and certain plastics reduce waste and conserve resources, while compostable packaging breaks down naturally, often made from organic materials. By adopting these sustainable solutions, pharmaceutical companies can minimize their environmental footprint, comply with regulations, and meet growing demand for eco-friendly products, ultimately enhancing brand reputation and customer loyalty while reducing waste disposal costs¹².

· Carbon footprint reduction initiatives:

The pharmaceutical industry is prioritizing carbon footprint reduction in packaging, driven by climate change concerns, sustainability goals, and regulatory requirements. Initiatives span the entire product lifecycle, from design and manufacturing to distribution and disposal, to minimize environmental impact and promote sustainable practices¹³. Pharmaceutical companies are optimizing packaging design to reduce material usage, weight, and enhance recyclability, thereby decreasing greenhouse gas emissions. They're also exploring sustainable materials like bioplastics, recycled materials, and biodegradable packaging to minimize environmental impact. Additionally, companies are implementing energy-efficient processes, investing in renewable energy, and promoting recycling and waste reduction programs. Some are adopting circular economy principles, designing reusable, recyclable, or biodegradable packaging to reduce waste and conserve resources. Supply chain optimization, including route planning and transportation mode selection, can also lower carbon emissions. By implementing these initiatives, pharmaceutical companies can reduce their environmental impact, enhance their brand reputation, comply with regulations, and contribute to a sustainable future. Effective carbon reduction requires collaboration across the value chain, from suppliers to end-users, to drive meaningful change and achieve significant environmental benefits. By prioritizing sustainability, the pharmaceutical industry can help mitigate climate change and promote a healthier environment¹⁴.

3. Nanotechnology in Packaging:

Figure 3: Functional properties of nanocomposite packaging materials in pharmaceuticals³²

· Nano-coatings for barrier properties:

Nano coating technology is revolutionizing pharmaceutical packaging by providing enhanced barrier properties to protect products from environmental factors. By applying a thin layer of nanomaterials (1-100 nanometers) to packaging materials, nano coatings effectively block gases, moisture, and other contaminants, ensuring the stability and efficacy of pharmaceutical products¹⁵.

Nano coatings in pharmaceutical packaging offer numerous benefits, including reduced permeability to gases, moisture, and other substances, protecting products from degradation and contamination. By controlling the internal environment, nano coatings help maintain product stability, potency, efficacy, and safety, ensuring high-quality pharmaceuticals¹⁶.Additionally, the improved barrier properties provided by nano coatings can extend the shelf life of pharmaceutical products, reducing the risk of spoilage or degradation. Furthermore, nano coatings can enable the use of thinner or lighter packaging materials, reducing the overall amount of material used and minimizing waste.

Nano coatings can be applied to various types of packaging materials, including blister packs, bottles and containers, and flexible packaging materials such as pouches or sachets. In each of these applications, nano coatings can enhance the barrier properties of the packaging material, protecting the product from moisture, oxygen, and other environmental factors.

Compared to traditional coatings, nano coatings offer several advantages. They can provide superior barrier properties, ensuring better protection for pharmaceutical products. Nano coatings can be applied in extremely thin layers, reducing the amount of material used and minimizing the impact on packaging design. Moreover, nano coatings can be tailored to specific applications and packaging materials, offering flexibility in design and functionality. While nano coatings offer numerous benefits, challenges and future directions remain. Large-scale production requires significant investment in equipment and technology, and compliance with regulatory requirements for safety and efficacy is crucial. Continued research and development are needed to improve performance, scalability, and cost-effectiveness. Despite these challenges, nano coatings have the potential to revolutionize pharmaceutical packaging, enhancing product protection, stability, efficacy, and safety while reducing waste and environmental impact, providing a more efficient, effective, and sustainable solution.

· Antimicrobial and moisture-resistant packaging:

Antimicrobial and moisture-resistant packaging plays a vital role in protecting pharmaceutical products from microbial contamination and moisture ingress. Antimicrobial packaging materials are treated with agents that inhibit the growth of microorganisms like bacteria, yeast, and mold, ensuring product quality and safety¹⁷. Moisture-resistant packaging prevents moisture entry, which can cause product degradation or clumping. Combining antimicrobial and moisture-resistant properties provides robust protection against environmental factors affecting product stability and efficacy. This packaging is crucial for moisture-sensitive or contamination-prone products like oral solids, injectables, and biologics. Effective solutions include coatings, films, and foils tailored to specific product needs and formats. By incorporating these properties, pharmaceutical companies enhance product protection, reduce contamination risk, and ensure regulatory compliance, ultimately maintaining patient safety and product efficacy^18,19.

4. Cold Chain and Temperature-Controlled Packaging:

Figur4. Cold chain packaging system with multi-layer insulated design for pharmaceuticals³³

· Insulated packaging for biologics and vaccines:

Insulated packaging is critical for transporting and storing biologicals and vaccines, which are sensitive to temperature fluctuations. Solutions like vacuum-insulated containers, thermal blankets, or phase change materials regulate temperature, preventing degradation and maintaining product potency and efficacy²⁰.Insulated packaging solutions maintain products within specific temperature ranges (2-8°C for refrigerated or frozen for cryogenic products), ensuring integrity and effectiveness of biologicals and vaccines. This is crucial for global vaccine distribution, where temperature fluctuations can occur during transportation. Tailored insulated packaging provides reliable temperature control, reducing spoilage risk and protecting public health²¹.

· Phase-change materials for temperature regulation:

Phase Change Materials (PCMs) play a crucial role in maintaining temperature stability in pharmaceutical packaging, particularly for temperature-sensitive products like biologics and vaccines. PCMs absorb or release heat energy as they change phase, regulating temperature and keeping products within a specified range. This ensures products remain stable and effective during transportation and storage. PCMs offer precise temperature control, increased product safety, and improved regulatory compliance, making them essential in pharmaceutical packaging. They can be tailored to specific temperature requirements, preventing product degradation, reducing waste, and ensuring medications remain potent and effective. By leveraging PCMs' unique properties, pharmaceutical companies can develop more effective and reliable packaging solutions that protect products and maintain efficacy^22,23.

5. Personalized and Patient-Centric Packaging:

Figure 5. Pill organizer as a compliance-enhancing packaging system for patients³⁴

Personalized and patient-centric packaging in the pharmaceutical industry provides tailored solutions that cater to individual patient needs, improving medication adherence, reducing errors, and promoting better health outcomes. It prioritizes patient care, satisfaction, and unique needs, enhancing the overall patient experience.

· Smart pill dispensers:

Smart pill dispensers are innovative devices that are transforming medication management by providing patients with a convenient, automated, and reliable way to manage their medications. These devices are designed to store and dispense medications at the right time, sending reminders and alerts to patients to take their medications as prescribed. Smart pill dispensers can be programmed to accommodate complex medication regimens, track adherence, and provide real-time monitoring, enabling healthcare providers to intervene early if adherence issues arise. Some smart pill dispensers also feature advanced functionalities such as automatic pill sorting, alerts for missed doses, and integration with wearable devices or mobile apps²⁴.By leveraging technology, smart pill dispensers can significantly improve medication adherence, reduce errors, and enhance patient outcomes, particularly for patients with chronic conditions or complex medication regimens. As part of the broader trend towards digital health and personalized medicine, smart pill dispensers represent a promising solution for optimizing medication management and improving patient care.

· Calendar-based blister packs for adherence:

Calendar-based blister packs are a type of packaging designed to improve medication adherence by providing a visual reminder of dosing schedules. These packs feature a calendar layout with blister cavities corresponding to specific dates, allowing patients to easily track their medication intake. Each blister is labeled with the day of the week or date, enabling patients to quickly identify which pills to take on a particular day. This design helps patients stay on schedule, reducing errors and improving adherence to medication regimens. Calendar-based blister packs are particularly beneficial for patients with chronic conditions or complex dosing schedules, as they provide a clear and organized way to manage medications. By enhancing patient engagement and facilitating adherence, these packaging solutions can contribute to better health outcomes and reduced healthcare costs²⁵. Overall, calendar-based blister packs represent a practical and effective solution for improving medication management and supporting patient care.

4. Evaluation Strategies for Pharmaceutical Packaging:

1. Physicochemical Testing of Packaging Materials:

· Moisture Barrier Testing:

Moisture barrier testing plays a vital role in verifying that packaging materials can safeguard products from moisture-induced degradation, which can compromise their stability, efficacy, and shelf life. By assessing the water vapor transmission rate (WVTR) of packaging materials, this testing determines the rate at which moisture permeates the material. Ultimately, moisture barrier testing enables the identification of suitable packaging materials that maintain a stable environment, thereby preventing product spoilage and ensuring its quality²⁶.

Various methods can be used, such as:

I. Gravimetric method: Measures weight gain or loss due to moisture absorption or desorption.

II. Infrared (IR) spectroscopy: Detects changes in moisture levels using IR absorption.

III. Electrolytic method: Uses an electrolytic sensor to measure moisture levels.

· Gas Permeability Analysis:

Gas permeability analysis assesses the rate at which gases, such as oxygen, carbon dioxide, or nitrogen, pass through packaging materials. This testing is essential for products sensitive to gas exposure, such as oxygen-sensitive pharmaceuticals or food products. Gas permeability can affect product stability, flavor, aroma, or texture.

Methods for gas permeability analysis include:

I. Gas transmission rate (GTR) testing: Measures the rate at which gas passes through the packaging material.

II. Permeability coefficient measurement: Calculates the permeability coefficient, which represents the material's gas barrier properties²⁷.

· Leachability and Extractability Studies:

Leachability and extractability studies evaluate the potential for packaging materials to leach or extract substances into the product, which can contaminate it and affect its safety and efficacy. These studies help ensure that packaging materials are compatible with the product and do not pose a risk to patient safety or product quality²⁸.

These studies involve:

I. Leachable studies: Identify and quantify substances that can leach from the packaging material into the product under normal storage and use conditions.

II. Extractable studies: Determine the potential for packaging materials to release substances under exaggerated conditions, such as high temperatures or solvents.

2. Mechanical and Performance Testing:

· Compression, Tensile Strength, and Drop Tests:

These tests evaluate the packaging material's mechanical strength and durability. These tests help ensure that packaging materials can withstand the rigors of transportation, storage, and handling, protecting the product and maintaining its quality.

I. Compression testing: Assesses the material's ability to withstand compressive forces, such as stacking or pressure during transportation.

II. Tensile strength testing: Measures the material's resistance to stretching or breaking under tension.

III. Drop testing: Simulates the impact of accidental drops during handling, evaluating the material's ability to withstand shock and maintain its integrity.

· Seal Integrity and Closure System Testing:

Seal integrity and closure system testing verify that the packaging material's seal and closure system are secure, leak-proof, and functional:

I. Seal strength testing: Measures the force required to open the seal.

II. Leak testing: Detects leaks or defects in the seal or closure system.

III. Closure system testing: Evaluates the functionality and integrity of the closure system, such as screw caps or snap-fit closures.

These tests ensure that the packaging material's seal and closure system maintain the product's sterility, prevent contamination, and ensure safe and convenient use²⁹.

3. Stability and Compatibility Studies:

· Interaction of Packaging with Drug Formulations:

These studies investigate potential interactions between the packaging material and the drug product, which can affect the product's stability, efficacy, or safety:

I. Compatibility testing: Evaluates the interaction between the packaging material and the drug product under various conditions, such as temperature, humidity, or light exposure.

II. Adsorption or absorption testing: Measures the potential for the packaging material to adsorb or absorb the active pharmaceutical ingredient (API) or other formulation components.

These studies help ensure that packaging materials are compatible with the drug product and do not affect its quality or efficacy³⁰.

· Effect of Light, Humidity, and Temperature:

These studies evaluate the impact of environmental factors on the packaging material and the drug product:

I. Light stability testing: Assesses the product's stability under various light conditions, such as UV or visible light.

II. Humidity testing: Evaluates the product's stability under various humidity conditions, such as high or low humidity.

III. Temperature testing: Assesses the product's stability under various temperature conditions, such as high or low temperatures.

IV. These studies help ensure that packaging materials can protect the product from environmental stressors and maintain its quality and efficacy.

4. Regulatory Compliance and Quality Control:

· USFDA, EMA, ICH Guidelines on Pharmaceutical Packaging:

Pharmaceutical packaging must comply with regulatory guidelines set by agencies like the USFDA, EMA, and ICH. USFDA guidelines provide guidance on packaging materials, labeling, and quality control. EMA guidelines offer guidance on packaging materials.

5. Stability Testing and Pharmacopoeial Standards:

Stability testing is one of the most critical evaluation strategies in pharmaceutical packaging, as it determines the ability of packaging systems to maintain the safety, efficacy, and quality of drug products throughout their intended shelf life. According to the International Council for Harmonisation (ICH) Q1A (R2) guideline, stability studies should assess the effect of environmental factors such as temperature, humidity, and light on both the drug product and its packaging. Real-time and accelerated stability studies are commonly employed to predict long-term performance. Packaging plays a central role in these studies because inappropriate container–closure systems can accelerate degradation, alter the physical characteristics of the product, or lead to leaching of harmful substances. Therefore, the compatibility of packaging materials with the formulation must be established under stress conditions before regulatory approval.

In addition to ICH guidance, pharmacopoeial standards provide detailed test procedures. The United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Indian Pharmacopoeia (IP) specify tests such as moisture vapor transmission rate, light transmission, extractables and leachables, and integrity testing for sterile packaging. These compendial methods serve as benchmarks for evaluating whether a packaging material can ensure product stability and patient safety. By integrating ICH recommendations with pharmacopoeial standards, manufacturers can generate robust data that supports regulatory submissions, assures healthcare professionals, and ultimately protects patients. Stability testing, therefore, is not only a scientific requirement but also a regulatory and ethical obligation in pharmaceutical packaging evaluation.

Future Perspectives and Challenges:

Although remarkable progress has been made in pharmaceutical packaging, several challenges remain that require innovative solutions. The rising demand for personalized medicine and biologics necessitates packaging systems that are highly adaptable yet cost-effective. Developing packaging materials that are both sustainable and compliant with stringent regulatory requirements is another major hurdle, especially as global policies are increasingly focused on reducing plastic waste and carbon emissions. Counterfeit medicines continue to threaten patient safety worldwide, highlighting the need for widespread adoption of serialization, blockchain, and other digital traceability solutions. At the same time, integration of smart packaging with Internet of Things (IoT) platforms raises concerns about data security, interoperability, and affordability in low-resource settings.

Future research should focus on developing multifunctional packaging that combines sustainability, advanced barrier properties, and digital intelligence without significantly increasing costs. Collaborative efforts between academia, industry, and regulatory agencies will be essential to establish harmonized global standards. By addressing these challenges, pharmaceutical packaging can evolve into a more patient-centric, environmentally responsible, and technologically advanced discipline.

CONCLUSION:

Pharmaceutical packaging has advanced far beyond its traditional protective role, becoming an integral component of drug quality, safety, and patient adherence. Innovations in smart technologies, sustainable materials, nanostructured coatings, and cold-chain solutions are redefining industry standards. At the same time, robust evaluation strategies, including stability studies and pharmacopoeial testing, remain essential to ensure reliability and regulatory compliance. Going forward, the challenge lies in harmonizing innovation with sustainability and affordability, so that advanced packaging solutions can benefit patients across diverse healthcare systems. By aligning technological progress with regulatory and environmental priorities, pharmaceutical packaging can continue to evolve as a critical driver of safer, more effective, and patient-centric therapies.

REFERENCES:

1. Das PS, Saha P, Das R. Pharmaceutical packaging technology: a brief outline. Research Journal of Pharmaceutical Dosage Forms and Technology. 2018; 10(1):23-8.

2. Gowda SR, Venkatesh R, Sreedhara A. Guardians of wellness: Innovations redefining safety and sustainability in pharmaceutical packaging. Asian Journal of Pharmacy and Technology. 2024; 14(4):346-54.

3. Gowda SR, Venkatesh R, Sreedhara A. Guardians of wellness: Innovations redefining safety and sustainability in pharmaceutical packaging. Asian J Pharm Technol. 2024; 14(2):123–9.

4. Rajeev S. Importance of Packaging in Supply Chain Management. PIMT. 2024 Mar 21:19.

5. Fang W, Li Z, Gao J, Meng R, He G, Hou Z, Zhu S, Zhou M, Zhou C, Xiao Y, Yu M. The joint and interaction effect of high temperature and humidity on mortality in China. Environment International. 2023 Jan 1; 171:107669.

6. Antons C, Garcia G. Initiatives on IP enforcement beyond TRIPS: the Anti-Counterfeiting Trade Agreement and the International Medical Products Anti-Counterfeiting Task Force. In: Antons C, editor. The Enforcement of Intellectual Property Rights. Alphen aan den Rijn: Wolters Kluwer; 2011. p. 125–59.

7. Therapeutic Goods Administration. Guideline for the Tamper-Evident Packaging of Medicines, Complementary Healthcare Products and Medical Devices. 1st ed. Canberra: TGA; 2000 Dec 22.

8. Payne Security. Anti-counterfeiting pharma: Combating drug counterfeiting using advanced packaging technologies. News and Events, Press Releases. 2010 Feb.

9. Avérous L, Pollet E. Environmental Silicate Nano-Biocomposites. Berlin: Springer; 2012. https://doi.org/10.1007/978-1-4614-2212-6

10. Ravindra P, Kandasubramanian B. Biodegradable plastics and polymers for pharmaceutical packaging: A review. Environ Chem Lett. 2021; 19(4):3117–3142. https://doi.org/10.1007/s10311-021-01192-6

11. Siracusa V, Rocculi P, Romani S, Dalla Rosa M. Biodegradable polymers for food packaging: A review. Trends Food Sci Technol. 2008; 19(12):634–643. https://doi.org/10.1016/j.tifs.2008.07.003

12. Marsh K, Bugusu B. Food packaging—roles, materials, and environmental issues. J Food Sci. 2007; 72(3):R39–R55. https://doi.org/10.1111/j.1750-3841.2007.00301.x

13. Wiedmann T, Minx J. A definition of carbon footprint. ISAUK Research Report 07-01. Durham: ISAUK Research & Consulting; 2007.

14. Poonam Madhukar Kasar, Cynthia Sunil Tribhuwan, Jyoti Gokul Khode. Innovative Packaging of Medicines. Asian J. Res. Pharm. Sci. 2020; 10(1):56-60..

15. Somsubhra Ghosh, Sowjanya Bomma, V. Laxmi Prasanna, P. Srivani, David Bhanji. New Analytical Methods in Nanotechnology-A Review. Asian J. Res. Pharm. Sci. 3(1): Jan.-Mar. 2013; Page 31-41.

16. Kiran Patole, Anil Danane, Amit Nikam, Anuja Patil. Review on Nanotechnology and its utilization in Pharmaceuticals. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(4):319-322.

17. Prasad P, Kochhar A. Active packaging in food industry: A review. IOSR J Environ Sci Toxicol Food Technol. 2014; 8(5):01–07.

18. Singh SP, Singh H, Grewal S. Recent trends in packaging of pharmaceuticals: A review. Int J Res Pharm Nano Sci. 2015; 4(6):347–354.

19. Sorrentino A, Gorrasi G, Vittoria V. Potential perspectives of bio-nanocomposites for food packaging applications. Trends Food Sci Technol. 2007; 18(2): 84–95. https://doi.org/10.1016/j.tifs.2006.09.004

20. Agarwal S, Ray S, Singh S. Cold chain management in pharmaceutical industry. J Drug Deliv Ther. 2021; 11(3): 163–170. https://doi.org/10.22270/jddt.v11i3.4783

21. Ibragim Musaevich Bamatov, Anatolij Sergeevich Utyuzh, Vladimir Dmitriyevich Sekerin, Anna Evgenyevna Gorokhova, Dmitrii Anatolievich Shevchenko, Natalia Viktorovna Gayduk. Selecting a provider as the most important step in building a cold chain in Pharmaceutical Logistics. Research J. Pharm. and Tech. 2020; 13(10):4641-4647.

22. Amitkumar J. Vyas, Sinchan M. Patel, Ashok B. Patel, Ajay I. Patel, Nilesh K. Patel, Suuny Shah, Devang Sheth. Stability testing: An Essential study for Vaccine Formulation Development. Asian Journal of Pharmaceutical Research. 2022; 12(1):29-36.

23. Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2020; 14: 1009–1020. https://doi.org/10.2147/TCRM.S14559

24. Choudhury A, Asan O, McDonald C. Smart medication adherence monitoring devices: A literature review. Proc Hum Factors Ergon Soc Annu Meet. 2019; 63(1): 1073–1077. https://doi.org/10.1177/1071181319631176

25. Vernon M, Downey A, Lyons J. Blister packaging and adherence: A review of patient compliance and behavior. J Pharm Innov. 2017; 12(1):45–53. https://doi.org/10.1007/s12247-017-9264-2

26. Suraj Kushe Shekhar, Raveendran P.T. Product Packaging and Competitive Advantage. Asian J. Management. 2016; 7(1): 1-4.

27. Moghadam TT, Ghasemi Y, Omidi M. Barrier properties of pharmaceutical packaging materials: A review. Iran J Pharm Res. 2020; 19(1):1–14.

28. U.S. Food and Drug Administration (FDA). Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. Silver Spring (MD): FDA; 2020.

29. United States Pharmacopeia. USP <1207> Package Integrity Evaluation – Sterile Products. Rockville (MD): United States Pharmacopeia; 2021.

30. European Medicines Agency (EMA). Guideline on Plastic Immediate Packaging Materials. Amsterdam: EMA; 2019. Also see: ICH. Q8(R2) Pharmaceutical Development. Geneva: International Council for Harmonisation; 2009.

31. Das PS, Saha P, Das R. Pharmaceutical packaging technology: a brief outline. Res J Pharm Dosage Forms Technol. 2018; 10(1):23–8.

32. Roy S, Rhim JW. Emerging trends in nanocomposite packaging for food and pharmaceutical applications: A review. Int J Biol Macromol. 2023; 231:123456.

33. Jena S, Panda S, Nayak AK. Cold chain logistics and temperature-controlled packaging in pharmaceuticals: Recent advances and future prospects. J Pharm Innov. 2022; 17(6):1450–62.

34. Arora A, Dhingra N, Gupta S. Role of innovative packaging in improving patient compliance: An overview. Int J Pharm Sci Res. 2021; 12(8):1000–7.

Received on 13.07.2025 Revised on 18.08.2025

Accepted on 20.09.2025 Published on 20.01.2026

Available online from January 27, 2026

Asian J. Pharm. Tech. 2026; 16(1):73-80.

DOI: 10.52711/2231-5713.2026.00011

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.